🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
66.89
-1.71 (-2.49%)
At close: Nov 20, 2026, 4:00 PM EST
67.48
+0.59 (0.89%)
After-hours: Nov 20, 2026, 7:30 PM EST

Globus Medical Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
441.27526.16784.44467.29150.47193.07
Short-Term Investments
76.1631.09105.6250.5295.59250.38
Cash & Short-Term Investments
517.44557.24890.06517.79446.06443.45
Cash Growth
32.50%-37.39%71.90%16.08%0.59%3.91%
Accounts Receivable
675.3678.94557.7503.24213.25164.44
Other Receivables
48.6564.7320.631.644.061.22
Receivables
723.95743.67578.33504.87217.31165.65
Inventory
824.14759.28659.23848.14298.98237
Prepaid Expenses
116.4465.4349.6444.582118.42
Total Current Assets
2,1822,1262,1771,915983.34864.52
Property, Plant & Equipment
590.14628.96612.07647.66249.72221.08
Long-Term Investments
353.7471.8266.1375.43495.85562.48
Goodwill
1,4541,4351,4321,435197.47179.71
Other Intangible Assets
667.47745.06795.12924.663.5768.66
Long-Term Deferred Tax Assets
205.94218.2294.210.6948.8524.49
Other Long-Term Assets
75.3878.0674.5877.7937.3236.33
Total Assets
5,5285,3035,2525,0862,0761,957

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
107.4398.8575.1256.6736.121.96
Accrued Expenses
269.9281.36253.61230.6586.6187.24
Current Portion of Long-Term Debt
--443.35---
Current Portion of Leases
14.4815.0910.4812.442.54-
Current Income Taxes Payable
5.844.1610.733.850.991.05
Current Unearned Revenue
27.8127.6622.1418.3714.112.03
Other Current Liabilities
82.4771.3940.4970.3718.8717.89
Total Current Liabilities
507.94498.5855.91392.35159.2140.16
Long-Term Debt
---417.4--
Long-Term Leases
93.7104.3583.8991.373.48-
Long-Term Deferred Tax Liabilities
31.623.7623.8984.421.784.31
Other Long-Term Liabilities
91.36102.9110.73102.5865.371.4
Total Liabilities
731.94729.511,0741,088229.75215.88

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.130.140.140.140.10.1
Additional Paid-In Capital
3,2593,1703,0312,871630.95553.79
Retained Earnings
1,5251,3881,1531,1371,2401,194
Comprehensive Income & Other
11.3415.35-6.86-10.19-24.63-6.77
Shareholders' Equity
4,7964,5734,1773,9981,8461,741
Total Liabilities & Equity
5,5285,3035,2525,0862,0761,957

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
108.19119.44537.72521.226.01-
Net Cash (Debt)
762.99509.62418.4772935.91,006
Net Cash Growth
165.76%21.78%481.20%-92.31%-6.96%28.89%
Net Cash Per Share
5.573.723.040.639.129.71
Filing Date Shares Outstanding
132.47135.25137.54135.37100.3101.56
Total Common Shares Outstanding
132.67135.06137.42136.34100.19101.54
Working Capital
1,6741,6271,3211,523824.14724.35
Book Value Per Share
36.1533.8630.4029.3218.4317.15
Tangible Book Value
2,6752,3931,9501,6391,5851,493
Tangible Book Value Per Share
20.1717.7214.1912.0215.8214.70
Land
10.8210.859.739.758.288.3
Buildings
127.78127.57100.13102.4551.5144.67
Machinery
1,1221,072956.23878.41508.88443.25
SEC Filings: 10-K · 10-Q